Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.05%||172.12||0.7%||$1087.70m|
|MRK||Merck & Co., Inc.||-0.95%||76.14||0.7%||$646.03m|
|LLY||Eli Lilly & Co.||1.24%||246.53||1.1%||$585.44m|
|BMY||Bristol-Myers Squibb Co.||0.22%||68.02||1.0%||$581.22m|
|NRXP||NRX Pharmaceuticals, Inc.||6.72%||16.20||0.0%||$179.06m|
|NVO||Novo Nordisk A/S||0.44%||93.01||0.1%||$81.74m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||-5.75%||118.76||0.0%||$80.43m|
PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.